| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 558 | 533 | +4.6% |
| EBITDA | 0.5 | 5.8 | −91.0% |
| EBITDA margin | 0.1% | 1.1% | −1.0 pts |
| Profit before tax | −25.8 | −22.3 | — |
| Net profit | −19.3 | −16.0 | — |
| EPS | −₹3.78 | −₹3.13 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 1,061 | — | — | |
| 15.3 | 15.3 | 12.3 | |
| 530 | 530 | 489 | |
| 1,576 | — | — | |
| 2,013 | 1,988 | 1,870 | |
| — | +6.3% | — | |
| 122 | 127 | 104 | |
| 6.1% | 6.4% | 5.5% | |
| 66.4 | 72.6 | 53.6 | |
| 0.2 | 3.5 | −23.4 | |
| 0.0% | 0.2% | −1.3% | |
| ₹0.04 | ₹0.69 | −₹4.58 | |
| — | +115.1% | — | |
| — | 171 | 6.2 | |
| — | −169 | −71.3 | |
| 2.4 | 2.4 | −65.1 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|
| Market Capitalization | — | — | 1,060.8 | |
| - Cash, Equiv & ST Investments | 12.3 | 15.3 | 15.3 | |
| + Total Debt | 489.4 | 530.1 | 530.1 | |
| Enterprise Value | — | — | 1,575.6 | |
| Revenue | 1,870.3 | 1,987.9 | 2,012.6 | |
| Growth %, YoY | — | +6.3 | — | |
| EBITDA | 103.6 | 127.1 | 121.9 | |
| Margin % | 5.54 | 6.39 | 6.06 | |
| EBIT | 53.6 | 72.6 | 66.4 | |
| Net Income | -23.4 | 3.5 | 0.2 | |
| Margin % | -1.25 | 0.18 | 0.01 | |
| EPS, Adj (current shares) | -4.58 | 0.69 | 0.04 | |
| Growth %, YoY | — | +115.1 | — | |
| Cash from Operations | 6.2 | 171.3 | — | |
| Capital Expenditures | -71.3 | -168.9 | — | |
| Free Cash Flow | -65.1 | 2.4 | 2.4 | |
Prices at the previous close · figures from the company's filings with NSE
Godavari Biorefineries (NSE: GODAVARIB) had a market capitalisation of ₹1,061 crore at the previous close (₹207.28 a share), a PE ratio of 4,708.2 on the last four quarters' profit and a price-to-book ratio of 1.35. In FY26 its consolidated net profit was ₹3.5 crore on revenue of ₹1,988 crore; in Q1 FY27 (April–June 2026) it was a loss of ₹19.3 crore. Its debt-to-equity ratio was 0.67 on 31 March 2026. Promoters held 63.31% of the shares on 30 September 2026.
Godavari Biorefineries' PE ratio is 4,708.2 at the previous close (₹207.28 a share): a market capitalisation of ₹1,061 crore divided by consolidated net profit of ₹23 lakh over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹3.5 crore) it is 300.7. These four quarters include net exceptional items of −₹31.1 crore (one-off charges reported separately), so the ratio on recurring profit would differ.
Godavari Biorefineries' price-to-book (PB) ratio is 1.35 at the previous close: a market capitalisation of ₹1,061 crore divided by shareholders' equity (book value) of ₹788 crore on 31 March 2026. That is a book value of ₹154.04 per share against a share price of ₹207.28.
In FY26, Godavari Biorefineries' return on equity (ROE) was 0.5% and its return on capital employed (ROCE) was 6.5%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
Godavari Biorefineries' market capitalisation was ₹1,061 crore at the previous close: 5.12 crore shares at ₹207.28 each.
No. Godavari Biorefineries had borrowings of ₹530 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.67. Its cash and current investments were ₹32.2 crore, so its net debt was ₹498 crore.
Godavari Biorefineries' basic earnings per share (EPS) were ₹0.69 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹0.03.
Godavari Biorefineries' debt-to-equity ratio was 0.67 on 31 March 2026: borrowings of ₹530 crore against total equity of ₹788 crore. A year earlier, on 31 March 2025, it was 0.63.
Godavari Biorefineries' net worth — shareholders' equity in its consolidated balance sheet — was ₹788 crore on 31 March 2026, up 0.8% from ₹782 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,061 crore at the previous close.
Promoters held 63.31% of Godavari Biorefineries on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Godavari Biorefineries' book value per share was ₹154.04 on 31 March 2026: shareholders' equity of ₹788 crore divided by the 5.12 crore shares in issue, up 0.8% from ₹152.80 a year earlier. The share price at the previous close was ₹207.28.
In FY26, Godavari Biorefineries generated ₹171 crore of cash from operations and spent ₹169 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹2.4 crore. In FY25 it was −₹65.1 crore.
Godavari Biorefineries' latest results are for Q1 FY27 (April–June 2026), filed on 5 August 2026: consolidated net loss ₹19.3 crore, wider than the loss of ₹16 crore in Q1 FY26; revenue from operations ₹558 crore, up 4.6% year on year.
On 30 September 2026, Godavari Biorefineries' shares were held by promoters 63.31%, foreign portfolio investors (FII/FPI) 0.22%, domestic institutions (DII) 9.96% (including mutual funds at 8.79%) and retail and other non-institutional investors 26.51%. Over the year, FII holding was down 0.38 percentage points from 0.60% and DII holding was down 2.02 percentage points from 11.98%.
On FY26 consolidated figures, against Davangere Sugar and Hindustan Foods: Godavari Biorefineries' operating margin of 3.7% is the lowest of the three (Davangere Sugar 15.0%, Hindustan Foods 6.4%; peer average 10.7%); its return on equity of 0.5% is the lowest of the three (Davangere Sugar 2.0%, Hindustan Foods 14.5%; peer average 8.2%).
In FY26, Godavari Biorefineries earned net profit of ₹3.5 crore on revenue of ₹1,988 crore, against ₹8.5 crore on ₹239 crore for Davangere Sugar. Godavari Biorefineries' operating margin was 3.7% (Davangere Sugar 15.0%) and its return on equity 0.5% (Davangere Sugar 2.0%).
In FY26 (April 2025–March 2026), Godavari Biorefineries' consolidated net profit was ₹3.5 crore, against a loss of ₹23.4 crore in FY25, on revenue from operations of ₹1,988 crore (up 6.3%).
Godavari Biorefineries will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
From Godavari Biorefineries' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.